
ARROWHEAD PHARMACEUTICALS, INC. ARWR
ARROWHEAD PHARMACEUTICALS, INC. statistics & valuation
Net margin-160.6%
FCF margin-63.0%
Return on capital-49.6%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Net margin (%)Gross margin (%)Operating margin (%)Return on equity (%)Shares outstandingNet debt ($)Share buybacks ($)Return on assets (%)Free cash flow margin (%)Debt / equity (×)EPS ($) Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|
| Operating margin | -156.9% | 11.9% | -16927.1% | -85.2% | -73.4% | -107.8% | -105.9% | 36.3% | -346.5% | -117.8% |
| Net margin | -160.6% | -0.2% | -16882.4% | -85.3% | -72.4% | -101.9% | -96.1% | 40.3% | -337.3% | -109.5% |
| FCF margin | -63.0% | 18.9% | -17018.3% | -137.3% | -77.7% | 106.8% | -122.5% | 95.4% | -301.3% | -101.4% |
| Return on assets | -41.7% | -0.1% | -52.6% | -26.8% | -25.4% | -19.8% | -16.2% | 19.4% | -48.8% | -33.1% |
| Return on equity | -1434.0% | -0.3% | -313.8% | -71.5% | -42.1% | -34.5% | -18.3% | 27.8% | -56.8% | -42.2% |
| Current ratio | 4.14 | 4.86 | 6.74 | 3.95 | 2.92 | 2.62 | 7.92 | 2.73 | 6.37 | 3.63 |
Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.